Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Medication Adherence Startup Raises $1.6 Million in Funding


Health App

Goove’s mobile app collects patient data and combines it with existing healthcare data to paint a picture of that user’s medication adherence level.

Share this!

August 9, 2017 | by Sarah Hand, M.Sc.

Using predictive analytics and individualized patient engagement strategies, digital health startup Groove Health hopes to improve medication adherence. The Chicago-based company has raised $1.6 million to help support their platform.

Medication adherence is a major problem in the US, accounting for between 30 and 50 percent of all treatment failures. It’s estimated that failure to take medication as prescribed contributes to 125,000 deaths each year and costs the US healthcare system over $100 billion annually.

“Medication adherence is a major challenge in healthcare today, with significant implications for medical outcomes,” said Andrew Hourani, Groove Health's Founder and CEO. “Interestingly enough, adherence is a behavioral issue, not a medical one. At Groove Health, our interest lies at the intersection of data analysis and behavioral psychology. How can aggregated data help us identify the causative factors of non-adherence, and how can we influence patient behavior accordingly?”

Goove’s mobile app collects patient data and combines it with existing healthcare data to paint a picture of that user’s medication adherence level. Using this data, the patient engagement program is initiated which encourages healthy behaviours – particularly in patients at high risk of non-adherence to medication schedules – through app-based outreach.

The company is reportedly partnering with many players in the healthcare space, including health insurers, pharmacies, and hospitals. According to Hourani, collaboration between all stakeholders is important to addressing the medication adherence issue and ultimately improving patients’ quality of life.

“The complex nature of medication adherence demands solutions that are more innovative than simple medication reminders,” said Hourani. “Health literacy, financial concerns, social issues, and other factors often influence non-adherent behavior. We are helping our enterprise customers identify and address these issues on an individualized basis.”

Keywords:  Medication Adherence, Health App, Patient Data


Share this with your colleagues!

Exclusion Criteria for Clinical Trials Poses Major Barrier to Patient Enrollment

August 17, 2017 - UT Southwestern researchers say that clinical investigators continue to increase the number of exclusion criteria, preventing more patients from participating in clinical trials.

Featured In: Clinical Trials News

Targeting Cellular Nitrogen Metabolism Could Offer a New Treatment for Pancreatic Cancer

August 17, 2017 - An enzyme involved in regulating the amount of nitrogen in the cell could be a new drug target for pancreatic cancer, according to researchers from Boston Children's Hospital and the Broad Institute of MIT and Harvard.

Featured In: Life Science News

Regeneron’s Drug for Respiratory Syncytial Virus Fails in Phase III Clinical Trial

August 16, 2017 - Biotechnology company Regeneron has announced it will not continue development of its antibody drug, suptavumab, after a failure in a Phase III clinical trial.

Featured In: Clinical Trials News


One Patient’s Perspective on Clinical Trials


Planning and Conducting Trials of the Latest Immunotherapies

ISO 13485:2016 for Medical Device Manufacturers: Ensuring a Smooth Transition through Effective Preparation

Medical Devices: Reviewing Regulatory Changes in the US and EU

Moving Beyond Regulatory and Performance Metrics in Starting Clinical Trials

Copyright © 2016-2017 Honeycomb Worldwide Inc.